Stocks and Investing Stocks and Investing
Fri, January 27, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Maintained (ALLK) at Hold with Increased Target to $8 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (TFIN) at Buy with Decreased Target to $67 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Matt Olney Maintained (TFIN) at Hold with Decreased Target to $58 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Scott Graham Downgraded (TER) to Hold and Held Target at $102 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Moore Maintained (TER) at Hold with Increased Target to $101 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Gus Richard Maintained (TER) at Hold with Increased Target to $97 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Vedvati Shrotre Maintained (TER) at Strong Buy and Held Target at $120 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Arcuri Maintained (TER) at Strong Buy with Increased Target to $125 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Christian Schwab Maintained (TER) at Strong Buy with Increased Target to $131 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Vivek Arya Maintained (TER) at Hold with Increased Target to $115 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Howard Ma Initiated (TDC) at Hold on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (TASK) at Hold with Increased Target to $20 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Scott Group Downgraded (ALK) to Hold on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Brandon Oglenski Maintained (ALK) at Hold with Increased Target to $54 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jamie Baker Maintained (ALK) at Buy with Increased Target to $91 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (AJG) at Hold with Increased Target to $215 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $233 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ken Newman Maintained (AIT) at Buy with Increased Target to $162 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
David Manthey Maintained (AIT) at Hold with Increased Target to $160 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Chris Dankert Maintained (AIT) at Strong Buy with Increased Target to $170 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Upgraded (AKRO) to Buy and Held Target at $65 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Howard Ma Initiated (BASE) at Strong Buy and Held Target at $20 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jason Gursky Maintained (BA) at Strong Buy with Increased Target to $248 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Aleksey Yefremov Maintained (AXTA) at Buy with Increased Target to $32 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Parkinson Maintained (AXTA) at Strong .. y with Increased Target to $31 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ghansham Panjabi Maintained (AXTA) at Buy with Increased Target to $35 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
James Ainley Maintained (ARMK) at Hold with Increased Target to $45 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (APPF) at Buy with Increased Target to $141 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Liesch Maintained (AX) at Buy with Increased Target to $50 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $6 on, Jan 27th, 2023

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $6 on, Jan 27th, 2023


Published on 2024-10-28 01:09:55 - WOPRAI, Roanna Ruiz
  Print publication without navigation


Roanna Ruiz of SVB Leerink, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $8 to $6 on, Jan 27th, 2023.

Roanna has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna

  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $4 on, Tuesday, January 24th, 2023
Contributing Sources